April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Potentiation of Visible Light-Induced Photodamage in Cultured RPE Cells by Treatment With AY9944, A 7-Dehydrocholesterol Reductase Inhibitor
J. W. Lee; J. Sanchez; R. Riddick; J.-D. Huang; S. J. Fliesler; I. R. Rodriguez
Author Affiliations & Notes
  • J. W. Lee
    Mechanisms of Retinal Disease Section, LRCMB, National Eye Institute, NIH, Bethesda, Maryland
  • J. Sanchez
    Mechanisms of Retinal Disease Section, LRCMB, National Eye Institute, NIH, Bethesda, Maryland
  • R. Riddick
    Mechanisms of Retinal Disease Section, LRCMB, National Eye Institute, NIH, Bethesda, Maryland
  • J.-D. Huang
    Mechanisms of Retinal Disease Section, LRCMB, National Eye Institute, NIH, Bethesda, Maryland
  • S. J. Fliesler
    Ophthalmology & Biochemistry, SUNY-Buffalo and VAWNYHS (Res. Service), Buffalo, New York
  • I. R. Rodriguez
    Mechanisms of Retinal Disease Section, LRCMB, National Eye Institute, NIH, Bethesda, Maryland
  • Footnotes
    Commercial Relationships  J.W. Lee, None; J. Sanchez, None; R. Riddick, None; J.-D. Huang, None; S.J. Fliesler, None; I.R. Rodriguez, None.
  • Footnotes
    Support  NEI intramural research program (IRR), EY007361 (SJF) and RPB (SJF)
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 1843. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Potentiation of Visible Light-Induced Photodamage in Cultured RPE Cells by Treatment With AY9944, A 7-Dehydrocholesterol Reductase Inhibitor
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      J. W. Lee, J. Sanchez, R. Riddick, J.-D. Huang, S. J. Fliesler, I. R. Rodriguez; Potentiation of Visible Light-Induced Photodamage in Cultured RPE Cells by Treatment With AY9944, A 7-Dehydrocholesterol Reductase Inhibitor. Invest. Ophthalmol. Vis. Sci. 2009;50(13):1843.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : To determine if accumulation of 7-dehydrocholesterol (7DHC) sensitizes RPE cells to visible light-induced photodamage. Also, to identify 7DHC-derived cytotoxic compounds generated by photo-oxidation.

Methods: : ARPE19 cells were treated with various concentrations of AY9944 in serum-free medium. 7DHC levels were determined by HPLC 24 and 48 h post-treatment. AY9944-treated cells were exposed to white light (570~650 lux) for 5-7 days at 37°C or kept in complete darkness (controls). Cell morphology was monitored by light microscopy. Apoptosis was detected using a TUNEL assay (Roche). 7-dehydrocholesterol reductase (DHCR7) mRNA expression was measured by qRT-PCR. Cell pellets and conditioned media were collected and aqueous- and lipid-soluble extracts were tested for cytotoxicity using a cellular dehydrogenase cell viability assay. The cytotoxic lipid extract was subfractionated by HPLC. The toxic subfractions were analyzed by LCMS.

Results: : ARPE19 cells contain levels of DHCR7 mRNA comparable to those in human brain. AY9944 (3 µM) treatment alone increased the levels of 7DHC by 50-fold relative to untreated controls in 48 h without compromising cell viability or morphology. AY9944-treated cells exposed to constant visible light died in 5-7 days, while AY9944-treated cells kept in the dark remained healthy. Lipid extracts from the dead cells caused cell death when given to fresh ARPE19 cells. Identification of the cytotoxic components by LCMS is in progress.

Conclusions: : 7DHC accumulation potentiates visible light-induced photodamage of cultured RPE cells. These findings may have important implications to retinal degeneration in patients with Smith-Lemli-Opitz syndrome (SLOS), where DHCR7 is defective. Finding ways to block the formation of cytotoxic 7DHC by-products may provide a useful therapeutic intervention in SLOS, particularly with respect to retinal photodamage.

Keywords: radiation damage: light/UV • lipids • retinal degenerations: cell biology 
© 2009, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2024 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept